Virbac

Virbac, established in 1968 and headquartered in Carros, France, is a specialized global leader in the veterinary pharmaceutical industry. The company focuses on the research, development, manufacturing, and distribution of comprehensive animal health solutions. Its extensive portfolio includes vaccines, antibiotics, anesthetics, and dermatological treatments designed to address complex health conditions in both companion animals and livestock. By providing advanced medical and nutritional products, Virbac supports the evolving needs of veterinarians, farmers, and pet owners worldwide.

Operating with a robust workforce of 5,000-10,000 employees, Virbac maintains a significant international footprint across 9 strategic locations. The organization leverages its global infrastructure to deliver specialized healthcare protocols and diagnostic tools. Meet Virbac's team to understand the leadership and operational expertise driving the company's commitment to animal welfare and scientific innovation. The firm’s operational model emphasizes high-quality manufacturing standards and a deep understanding of the veterinary market, ensuring consistent delivery of essential healthcare products across diverse geographic regions.

Virbac’s product range encompasses specialized solutions for pest control, inflammation, dental care, and ophthalmological conditions. The company’s dedication to animal health is reflected in its diverse offerings, which include antiparasitics and advanced nutritional supplements. Listed on the Euronext Paris exchange under the ticker EPA: VIRP, the firm continues to expand its influence in the global healthcare sector. Through its focus on specialized veterinary medicine, Virbac remains a pivotal entity in the animal health landscape, consistently delivering value to its stakeholders and the broader veterinary community.